Massachusetts H2435 mandates a review and report on APOL1 gene variants linked to end-stage renal disease.
Massachusetts H2435 requires the Department of Public Health to conduct a comprehensive review of APOL1 gene variants associated with increased risk of end-stage renal disease. The report must include recommendations for raising awareness, strategies and funding for increased screening and genetic testing, and other relevant information. The report is due by December 31, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.